Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander J Lepak

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Seminars in Respiratory and Critical Care Medicine|December 15, 2011
Antifungal PK/PD considerations in fungal pulmonary infectionsAlexander J Lepak, David R Andes
Antimicrobial Agents and Chemotherapy|May 25, 2016
In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection ModelAlexander J Lepak, David R Andes
Cold Spring Harbor Perspectives in Medicine|November 12, 2014
Antifungal pharmacokinetics and pharmacodynamicsAlexander J Lepak, David R Andes
Antimicrobial Agents and Chemotherapy|April 19, 2017
Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models against Staphylococcus aureusAlexander J Lepak, Miao Zhao, David R Andes
Bioorganic & Medicinal Chemistry|November 27, 2016
Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agentsMiao Zhao, Alexander J Lepak, David R Andes
Antimicrobial Agents and Chemotherapy|September 2, 2020
Pharmacodynamic Evaluation of MRX-8, a Novel Polymyxin, in the Neutropenic Mouse Thigh and Lung Infection Models against Gram-Negative PathogensAlexander J Lepak, Wen Wang, David R Andes
Antimicrobial Agents and Chemotherapy|December 17, 2014
Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis modelAlexander J Lepak, Karen Marchillo, David R Andes
Antimicrobial Agents and Chemotherapy|September 6, 2018
Pharmacodynamic Evaluation of Rezafungin (CD101) against Candida auris in the Neutropenic Mouse Invasive Candidiasis ModelAlexander J Lepak, Miao Zhao, David R Andes
Microbiology Spectrum|November 10, 2022
Diagnostic and Therapeutic Utility of Positive Intravascular Catheter Tip CulturesPatrizia Ulrich, Alexander J Lepak, Derrick J Chen
Antimicrobial Agents and Chemotherapy|February 26, 2026
Pharmacodynamic evaluation of BRII-693, a next-generation synthetic macrocyclic peptide antibiotic, in the neutropenic mouse thigh and lung infection models against gram-negative pathogensAlexander J Lepak, Yali Zhu, David R Andes
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Seminars in Respiratory and Critical Care Medicine|December 15, 2011
Antifungal PK/PD considerations in fungal pulmonary infectionsAlexander J Lepak, David R Andes
Antimicrobial Agents and Chemotherapy|May 25, 2016
In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection ModelAlexander J Lepak, David R Andes
Cold Spring Harbor Perspectives in Medicine|November 12, 2014
Antifungal pharmacokinetics and pharmacodynamicsAlexander J Lepak, David R Andes
Antimicrobial Agents and Chemotherapy|April 19, 2017
Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models against Staphylococcus aureusAlexander J Lepak, Miao Zhao, David R Andes
Bioorganic & Medicinal Chemistry|November 27, 2016
Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agentsMiao Zhao, Alexander J Lepak, David R Andes
Antimicrobial Agents and Chemotherapy|September 2, 2020
Pharmacodynamic Evaluation of MRX-8, a Novel Polymyxin, in the Neutropenic Mouse Thigh and Lung Infection Models against Gram-Negative PathogensAlexander J Lepak, Wen Wang, David R Andes
Antimicrobial Agents and Chemotherapy|December 17, 2014
Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis modelAlexander J Lepak, Karen Marchillo, David R Andes
Antimicrobial Agents and Chemotherapy|September 6, 2018
Pharmacodynamic Evaluation of Rezafungin (CD101) against Candida auris in the Neutropenic Mouse Invasive Candidiasis ModelAlexander J Lepak, Miao Zhao, David R Andes
Microbiology Spectrum|November 10, 2022
Diagnostic and Therapeutic Utility of Positive Intravascular Catheter Tip CulturesPatrizia Ulrich, Alexander J Lepak, Derrick J Chen
Antimicrobial Agents and Chemotherapy|February 26, 2026
Pharmacodynamic evaluation of BRII-693, a next-generation synthetic macrocyclic peptide antibiotic, in the neutropenic mouse thigh and lung infection models against gram-negative pathogensAlexander J Lepak, Yali Zhu, David R Andes
Pageof 7